Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2019 1
2020 7
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Experimental HER2- targeted therapies for biliary tract cancer.
Rizzo A, Ricci AD, Bonucci C, Tober N, Palloni A, Frega G, Brandi G. Rizzo A, et al. Among authors: tober n. Expert Opin Investig Drugs. 2021 Apr;30(4):389-399. doi: 10.1080/13543784.2021.1854724. Epub 2020 Dec 6. Expert Opin Investig Drugs. 2021. PMID: 33218269 Review.
Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow.
Rizzo A, Ricci AD, Tober N, Nigro MC, Mosca M, Palloni A, Abbati F, Frega G, DE Lorenzo S, Tavolari S, Brandi G. Rizzo A, et al. Among authors: tober n. Anticancer Res. 2020 Jun;40(6):3013-3030. doi: 10.21873/anticanres.14282. Anticancer Res. 2020. PMID: 32487595 Review.
PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?
Ricci AD, Rizzo A, Bonucci C, Tober N, Palloni A, Mollica V, Maggio I, Deserti M, Tavolari S, Brandi G. Ricci AD, et al. Among authors: tober n. Medicines (Basel). 2020 Aug 31;7(9):54. doi: 10.3390/medicines7090054. Medicines (Basel). 2020. PMID: 32878011 Free PMC article. Review.
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non-small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Dall'Olio FG, Gelsomino F, Conci N, Marcolin L, De Giglio A, Grilli G, Sperandi F, Fontana F, Terracciano M, Fragomeno B, Tober N, Manferrari G, Brocchi S, Golfieri R, Fiorentino M, Ardizzoni A. Dall'Olio FG, et al. Among authors: tober n. Clin Lung Cancer. 2021 Sep;22(5):423-431. doi: 10.1016/j.cllc.2021.03.005. Epub 2021 Mar 16. Clin Lung Cancer. 2021. PMID: 33849808